Modified Vaccine for High Risk or Low Residual Melanoma Patients
Clinical trial NCT01898039 · RECRUITING
Trial details
- NCT number
- NCT01898039
- Sponsor
- Hadassah Medical Organization
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2027-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.